InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AN2 Therapeutics, Inc.

ANTX Clue Score37
United States Fiscal year ends December CIK 0001880438 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Robin Shane Readnour
9 Sep 2026
Director
Sold on a plan indirect
585
$6.02
$3.52K
Robin Shane Readnour
9 Sep 2026
Director
Sold on a plan indirect
523
$6.02
$3.15K
Robin Shane Readnour
8 Sep 2026
Director
Sold on a plan indirect
5,294
$6.02
$31.86K
Robin Shane Readnour
8 Sep 2026
Director
Sold on a plan indirect
4,725
$6.02
$28.44K
Robin Shane Readnour
3 Sep 2026
Director
Sold on a plan indirect
3,223
$6.07
$19.56K
Robin Shane Readnour
3 Sep 2026
Director
Sold on a plan indirect
2,877
$6.07
$17.46K
Robin Shane Readnour
17 Aug 2026
Director
Sold on a plan indirect
18,706
$6.01
$112.39K
Robin Shane Readnour
17 Aug 2026
Director
Sold on a plan indirect
16,696
$6.01
$100.31K
Robin Shane Readnour
12 Jan 2024
Director
Sold on a plan indirect
719
$21.91
$15.75K
Robin Shane Readnour
12 Jan 2024
Director
Sold on a plan indirect
706
$21.92
$15.48K
Robin Shane Readnour
10 Jan 2024
Director
Sold on a plan indirect
1,800
$21.92
$39.46K
Robin Shane Readnour
10 Jan 2024
Director
Sold on a plan indirect
1,869
$21.93
$40.99K
Eric Easom
2 Jan 2024
Chief Executive Officer
Sold on a plan
2,777
$20.09
$55.80K
Kabeer Aziz
14 Nov 2023
Director
Sold on a plan indirect
288
$16.15
$4.65K
Kabeer Aziz
14 Nov 2023
Director
Sold on a plan indirect
1,522
$16.15
$24.57K
Adjuvant Global Health Technology Fund, L.P.
14 Nov 2023
10% owner
Sold on a plan indirect
288
$16.15
$4.65K
Adjuvant Global Health Technology Fund, L.P.
14 Nov 2023
10% owner
Sold on a plan
1,522
$16.15
$24.57K
Show all 140 transactions →

What was left out

Form 4 filings counted 186
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 2
Sales at will 84
Transactions with no price 0
Shares from compensation/vesting 9,487,058
Sales filed before the plan box existed 22
History held since 31 Mar 2022